Albuquerque R, Khan
Z, Poveda A, Higham J,
Richards A, Monteiro L, Jan-Salas
E, Lopez-Lopez J, Warnakulasuriya S. Management
of oral Graft versus Host Disease with topical agents: A systematic review. Med Oral Patol Oral Cir Bucal. 2016 Jan 1;21 (1):e72-81.
doi:10.4317/medoral.20968
http://dx.doi.org/doi:10.4317/medoral.20968
|
1. Billingham RE, Hings IM. The H-Y antigen and its role in natural transplantation.
Hum Genet. 1981;58:9-17. |
|
|
|
|
|
2. Mays J, Fassil H, Edwards D, Pavletic S, Bassim C. Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research. Oral Dis.
2013;19;327-46. |
|
|
|
|
|
3. Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen
EW, et al. National Institutes
of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis
and Staging Working Group Report. Biol Blood Marrow
Transplant. 2015;21:389-401. |
|
|
|
|
|
4.
Schubert MM, Correa ME. Oral graft-versus-host disease. Dent Clin North Am. 2008;52:79-109. |
|
|
|
|
|
5. Imanguli MM, Alevizos I, Brown
R, Pavletic SZ, Atkinson
JC. Oral graft-versus-host disease.
Oral Dis. 2008;14:396-412. |
|
|
|
|
|
6. Meier JK, Wolff D, Pavletic S, Greinix H, Gosau M, Bertz H, et al. International Consensus
Conference on Clinical Practice in cGVHD. Oral chronic graft-versus-host disease: report from the
International Consensus Conference
on clinical practice in cGVHD. Clin Oral Investig.
2011;15:127-39. |
|
|
|
|
|
7. Garg AX, Hackam D, Tonelli M. Systematic review and meta-analysis: when one study
is just not enough. Clin
J Am Soc Nephrol.
2008;3:253-60. |
|
|
|
|
|
8. Rossini G, Parrini S, Castroflorio T, Deregibus A, Debernardi CL. Periodontal health
during clear aligners treatment: a systematic review. Eur J Orthod. 2015;37:539-43. |
|
|
|
|
|
9. Bondemark L, Holm A, Hansen K, Axelsson S, Mohlin B, Brattstrom V. Long-term stability of orthodontic treatment and patient satisfaction. A systematic review. Angle Orthod. 2007;77,181-91. |
|
|
|
|
|
10. Elad S, Zeevi I, Finke J, Koldehoff M, Schwerdtfeger R, Wolff D, et al. Improvement
in oral chronic graft-versus-host
disease with the administration of effervescent tablets of topical budesonide-an open, randomized, multicenter study. Biol Blood
Marrow Transplant.
2012;18:134-40. |
|
|
|
|
|
11. Noce CW, Gomes A, Shcaira V, Corra ME, Moreira MC, Silva Jnior A, et al. Randomized double-blind clinical trial comparing clobetasol and dexamethasone for the topical
treatment of symptomatic
oral chronic graft-versus-host
disease. Biol Blood Marrow Transplant. 2014;20:1163-8. |
|
|
|
|
|
12.
Epstein JB, Reece DE. Topical
cyclosporin A for treatment of oral chronic graft-versus-host disease. Bone Marrow Transplant.
1994;13:81-6. |
|
|
|
|
|
13. Mawardi H, Stevenson K, Gokani
B, Soiffer R, Treister N.
Combined topical dexamethasone/tacrolimus therapy for management
of oral chronic GVHD. Bone
Marrow Transplant.
2010;45:1062-7. |
|
|
|
|
|
14.
Albert MH, Becker B, Schuster FR, Klein B, Binder V, Adam K, et al. Oral graft
vs. host disease in children--treatment with topical tacrolimus ointment. Pediatr Transplant. 2007;11:306-11. |
|
|
|
|
|
15.
Park AR, La HO, Cho BS, Kim SJ, Lee BK, Rhie JY, et al. Comparison of budesonide and dexamethasone for local treatment of oral chronic graft-versus-host disease. Am J Health Syst Pharm. 2013;70:1383-91. |
|
|
|
|
|
16.
Sari I, Altuntas F, Kocyigit
I, Sisman Y, Eser B, Unal
A, et al. The effect of budesonide mouthwash on oral chronic graft versus host disease. Am J
Hematol. 2007;82:349-56. |
|
|
|
|
|
17.
Epstein JB, Gorsky M, Epstein MS, Nantel S. Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases. Oral Surg
Oral Med Oral Pathol Oral
Radiol Endod.
2001;91:56-61. |
|
|
|
|
|
18. Conrotto D, Broccoletti R, Carcieri P, Giaccone L, Arduino PG. Topical tacrolimus and periodontal therapy
in the management of a
case of oral chronic GVHD characterized
by specific gingival localization. Case Rep Dent. 2014;2014:127219. |
|
|
|
|
|
19.
Brown RS, Edwards D, Walsh-Chocolaad T, Childs RW. Topical tacrolimus with custom trays in the treatment of severe oral chronic graft-versus-host disease refractory to a potent topical steroid therapy: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115:e26-30. |
|
|
|
|
|
20.
Rojas AG, Gonzlez GN, Venables GC, Araos HD. [Gran versus host disease with oral involvement: report of one case]. Rev Med Chil. 2008;136:1570-3. |
|
|
|
|
|
21. Fricain JC, Sibaud V, Swetyenga N, Tabrizi R, Campana
F, Taeb A. Long-term efficacy of topical tacrolimus on oral lesions of chronic graft-versus-host disease. Br J
Dermatol. 2007;156:588-90. |
|
|
|
|
|
22. Conrotto D, Carrozzo M, Ubertalli AV, Gandolfo S, Giaccone L, Boccadoro M, et al.
Dramatic increase of tacrolimus plasma concentration
during topical treatment for oral graft-versus-host disease. Transplantation. 2006;82:1113-5. |
|
|
|
|
|
23. Eckardt A, Starke O, Stadler M, Reuter C, Hertenstein
B. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation:
highly effective treatment with topical tacrolimus. Oral Oncol. 2004;40:811-4. |
|
|
|
|
|
24.
Snchez AR, Sheridan PJ, Rogers RS. Successful treatment of oral lichen planus-like chronic graft-versus-host disease with topical tacrolimus: a case report. J Periodontol. 2004;75:613-9. |
|
|
|
|
|
25. St John L, Gordon SM, Childs R,
Marquesen M, Pavletic SZ,
Wu TX, et al. Topical thalidomide gel in oral chronic
GVHD and role of in situ cytokine expression in monitoring biological activity. Bone Marrow Transplant.
2013;48:610-1. |
|
|
|
|
|
26. Zadik Y, Nakdimon I, Meyerowitz C, Shapira MY, Elad S. Topical budesonide for severe oral chronic graft-versus-host disease. Am J
Health Syst Pharm. 2014;71:181-2. |
|
|
|
|
|
27. Dechartres A, Boutron I, Roy C,
Ravaud P. Inadequate planning and reporting of adjudication committees in clinical trials: recommendation proposal. J Clin Epidemiol.
2009;62:695-702. |
|
|
|
|
|
28. Kahan BC, Cro S, Dor CJ, Bratton DJ, Rehal S, Maskell NA, et al. Reducing bias in open-label trials where blinded outcome assessment is not feasible: strategies from two randomised trials. Trials. 2014;15:456. |
|
|
|
|
|
29. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097. |
|
|
|
|
|
30. Dilger K, Halter J, Bertz H, Lopez-Lazaro L, Gratwohl A, Finke J. Pharmacokinetics and pharmacodynamic
action of budesonide after buccal administration in healthy subjects and patients with oral chronic graft-versus-host disease. Biol Blood Marrow
Transplant. 2009;15:336-43. |
|
|
|
|
|
31. Elad S, Jensen SB, Raber-Durlacher
JE, Mouradian N, Correa EM, Schubert MM, et al. Clinical approach in the management of oral chronic graft-versus-host disease (cGVHD) in a series of specialized medical centers. Support
Care Cancer.
2015;23:1615-22. |
|
|
|
|
|
32.
Thomson AW, Bonham CA, Zeevi
A. Mode of action of tacrolimus (FK506): molecular and cellular
mechanisms. Ther Drug Monit. 1995;17:584-91. |
|
|
|
|
|
33.
Thomson MA, Hamburger J, Stewart DG, Lewis HM. Treatment of erosive oral lichen planus with topical tacrolimus. J Dermatolog Treat. 2004;15:308-14. |
|
|
|
|
|
34. Thongprasom K, Chaimusig M, Korkij W, Sererat T, Luangjarmekorn L, Rojwattanasirivej
S. A randomized-controlled trial to compare topical cyclosporin with triamcinolone acetonide for the treatment
of oral lichen planus. J
Oral Pathol Med.
2007;36:142-6. |
|
|
|
|
|
35. Mawardi H, Elad S, Correa ME,
Stevenson K, Woo SB, Almazrooa
S, et al. Oral epithelial dysplasia
and squamous cell
carcinoma following allogeneic
hematopoietic stem cell transplantation: clinical presentation and treatment outcomes. Bone Marrow Transplant.
2011;46:884-91. |
|
|
|
|
|
36.
Curtis RE, Rowlings PA, Deeg
HJ, Shriner DA, Soce G, Travis LB, et al. Solid cancers
after bone marrow transplantation. N Engl J Med. 1997;336:897-904. |
|
|
|
|
|
37. Elad S, Or R, Garfunkel AA, Shapira MY. Budesonide: a novel treatment for oral chronic graft versus host disease. Oral
Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:308-11. |
|
|
|
|
|
38.
Van Schandevyl G, Bauters
T. Formulation of budesonide
mouthwash for the treatment of oral chronic graft-versus-host disease. J Oncol Pharm Pract. 2014;pii:
1078155214560654. [Epub ahead
of print]. |
|
|
|
|
|
39. Thongprasom K, Carrozzo M, Furness S, Lodi G. Interventions
for treating oral lichen planus. Cochrane Database Syst Rev.
2011;7:CD001168. |
|
|
|
|
|
40.
Carbone M, Arduino PG, Carrozzo
M, Caiazzo G, Broccoletti
R, Conrotto D, et al. Topical
clobetasol in the treatment of atrophic-erosive
oral lichen planus: a randomized controlled trial to compare two preparations with different concentrations. J
Oral Pathol Med.
2009;38:227-33. |
|